Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: RANKL, . Treffer: 26

2021

Alonso, N; Wani, S; Rose, L; Van't, Hof, RJ; Ralston, SH; Albagha, OME Insertion Mutation in Tnfrsf11a Causes a Paget's Disease-Like Phenotype in Heterozygous Mice and Osteopetrosis in Homozygous Mice.
J Bone Miner Res. 2021; 36(7):1376-1386 Doi: 10.1002/jbmr.4288
Web of Science PubMed FullText FullText_MUG

 

2020

Roessner, A; Smolle, M; Haybäck, J [Giant cell tumor of bone : Morphology, molecular pathogenesis, and differential diagnosis].
Pathologe. 2020; 41(2):134-142 Doi: 10.1007/s00292-020-00760-5
Web of Science PubMed FullText FullText_MUG

 

2019

Wieser, V; Sprung, S; Tsibulak, I; Haybaeck, J; Hackl, H; Fiegl, H; Marth, C; Zeimet, AG Clinical Impact of RANK Signalling in Ovarian Cancer.
Cancers (Basel). 2019; 11(6): Doi: 10.3390/cancers11060791 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Fessler, J; Husic, R; Schwetz, V; Lerchbaum, E; Aberer, F; Fasching, P; Ficjan, A; Obermayer-Pietsch, B; Duftner, C; Graninger, W; Stradner, MH; Dejaco, C Senescent T-Cells Promote Bone Loss in Rheumatoid Arthritis.
Front Immunol. 2018; 9(1):95-95 Doi: 10.3389/fimmu.2018.00095 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Schweighofer, N; Aigelsreiter, A; Trummer, O; Graf-Rechberger, M; Hacker, N; Kniepeiss, D; Wagner, D; Stiegler, P; Trummer, C; Pieber, T; Obermayer-Pietsch, B; Müller, H Direct comparison of regulators of calcification between bone and vessels in humans.
Bone. 2016; 88:31-38 Doi: 10.1016/j.bone.2016.04.016
Web of Science PubMed FullText FullText_MUG

 

Sigl, V; Owusu-Boaitey, K; Joshi, PA; Kavirayani, A; Wirnsberger, G; Novatchkova, M; Kozieradzki, I; Schramek, D; Edokobi, N; Hersl, J; Sampson, A; Odai-Afotey, A; Lazaro, C; Gonzalez-Suarez, E; Pujana, MA; Cimba, F; Heyn, H; Vidal, E; Cruickshank, J; Berman, H; Sarao, R; Ticevic, M; Uribesalgo, I; Tortola, L; Rao, S; Tan, Y; Pfeiler, G; Lee, EY; Bago-Horvath, Z; Kenner, L; Popper, H; Singer, C; Khokha, R; Jones, LP; Penninger, JM RANKL/RANK control Brca1 mutation- .
Cell Res. 2016; 26(7):761-774 Doi: 10.1038/cr.2016.69 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Mikalauskas, S; Račkauskas, R; Zeromskas, P; Strupas, K Giant Bauhin valve adenoma and laparoscopically assisted colonoscopic polypectomy.
Wideochir Inne Tech Maloinwazyjne. 2014; 9(3): 484-5. Doi: 10.5114/wiitm.2014.45045 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Leidenberger, P; Wald, A; Hohneder, A; Kühs, U; Mischinger, J; Aufderklamm, S; Gakis, G; Blumenstock, G; Stenzl, A; Schwentner, C Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy.
BJU Int. 2014; 113(1):152-159 Doi: 10.1111/j.1464-410X.2012.11759.x
Web of Science PubMed FullText FullText_MUG

 

2013

Glehr, M; Breisach, M; Walzer, S; Lohberger, B; Fürst, F; Friesenbichler, J; Rinner, B; Avian, A; Windhager, R; Leithner, A The influence of resveratrol on the synovial expression of matrix metalloproteinases and receptor activator of NF-kappaB ligand in rheumatoid arthritis fibroblast-like synoviocytes.
Z Naturforsch C. 2013; 68(7-8):336-342 Doi: 10.5560/ZNC.2013.68c0336
Web of Science PubMed FullText FullText_MUG

 

Goettsch, C; Babelova, A; Trummer, O; Erben, RG; Rauner, M; Rammelt, S; Weissmann, N; Weinberger, V; Benkhoff, S; Kampschulte, M; Obermayer-Pietsch, B; Hofbauer, LC; Brandes, RP; Schröder, K NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.
J Clin Invest. 2013; 123(11):4731-4738 Doi: 10.1172/JCI67603 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pichler, K; Loreto, C; Leonardi, R; Reuber, T; Weinberg, AM; Musumeci, G RANKL is downregulated in bone cells by physical activity (treadmill and vibration stimulation training) in rat with glucocorticoid-induced osteoporosis
HISTOL HISTOPATHOL. 2013; 28(9): 1185-1196.
Web of Science PubMed

 

Pichler, K; Musumeci, G; Vielgut, I; Martinelli, E; Sadoghi, P; Loreto, C; Weinberg, AM Towards a better understanding of bone bridge formation in the growth plate - an immunohistochemical approach.
Connect Tissue Res. 2013; 54(6):408-415 Doi: 10.3109/03008207.2013.828715
Web of Science PubMed FullText FullText_MUG

 

2012

Estrada, K; Styrkarsdottir, U; Evangelou, E; Hsu, YH; Duncan, EL; Ntzani, EE; Oei, L; Albagha, OM; Amin, N; Kemp, JP; Koller, DL; Li, G; Liu, CT; Minster, RL; Moayyeri, A; Vandenput, L; Willner, D; Xiao, SM; Yerges-Armstrong, LM; Zheng, HF; Alonso, N; Eriksson, J; Kammerer, CM; Kaptoge, SK; Leo, PJ; Thorleifsson, G; Wilson, SG; Wilson, JF; Aalto, V; Alen, M; Aragaki, AK; Aspelund, T; Center, JR; Dailiana, Z; Duggan, DJ; Garcia, M; Garcia-Giralt, N; Giroux, S; Hallmans, G; Hocking, LJ; Husted, LB; Jameson, KA; Khusainova, R; Kim, GS; Kooperberg, C; Koromila, T; Kruk, M; Laaksonen, M; Lacroix, AZ; Lee, SH; Leung, PC; Lewis, JR; Masi, L; Mencej-Bedrac, S; Nguyen, TV; Nogues, X; Patel, MS; Prezelj, J; Rose, LM; Scollen, S; Siggeirsdottir, K; Smith, AV; Svensson, O; Trompet, S; Trummer, O; van, Schoor, NM; Woo, J; Zhu, K; Balcells, S; Brandi, ML; Buckley, BM; Cheng, S; Christiansen, C; Cooper, C; Dedoussis, G; Ford, I; Frost, M; Goltzman, D; González-Macías, J; Kähönen, M; Karlsson, M; Khusnutdinova, E; Koh, JM; Kollia, P; Langdahl, BL; Leslie, WD; Lips, P; Ljunggren, Ö; Lorenc, RS; Marc, J; Mellström, D; Obermayer-Pietsch, B; Olmos, JM; Pettersson-Kymmer, U; Reid, DM; Riancho, JA; Ridker, PM; Rousseau, F; Slagboom, PE; Tang, NL; Urreizti, R; Van, Hul, W; Viikari, J; Zarrabeitia, MT; Aulchenko, YS; Castano-Betancourt, M; Grundberg, E; Herrera, L; Ingvarsson, T; Johannsdottir, H; Kwan, T; Li, R; Luben, R; Medina-Gómez, C; Palsson, ST; Reppe, S; Rotter, JI; Sigurdsson, G; van, Meurs, JB; Verlaan, D; Williams, FM; Wood, AR; Zhou, Y; Gautvik, KM; Pastinen, T; Raychaudhuri, S; Cauley, JA; Chasman, DI; Clark, GR; Cummings, SR; Danoy, P; Dennison, EM; Eastell, R; Eisman, JA; Gudnason, V; Hofman, A; Jackson, RD; Jones, G; Jukema, JW; Khaw, KT; Lehtimäki, T; Liu, Y; Lorentzon, M; McCloskey, E; Mitchell, BD; Nandakumar, K; Nicholson, GC; Oostra, BA; Peacock, M; Pols, HA; Prince, RL; Raitakari, O; Reid, IR; Robbins, J; Sambrook, PN; Sham, PC; Shuldiner, AR; Tylavsky, FA; van, Duijn, CM; Wareham, NJ; Cupples, LA; Econs, MJ; Evans, DM; Harris, TB; Kung, AW; Psaty, BM; Reeve, J; Spector, TD; Streeten, EA; Zillikens, MC; Thorsteinsdottir, U; Ohlsson, C; Karasik, D; Richards, JB; Brown, MA; Stefansson, K; Uitterlinden, AG; Ralston, SH; Ioannidis, JP; Kiel, DP; Rivadeneira, F Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture.
NAT GENET. 2012; 44(5): 491-501. Doi: 10.1038/ng.2249 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Balic, M; Petru, E; Raunik, W; Singer, CF; Steger, GG; Watzke, IM; Brodowicz, T Treatment of Bone Metastases in Patients with Advanced Breast Cancer.
Breast Care (Basel). 2012; 7(2):92-98 Doi: 10.1159/000338650 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Malliga, DE; Wagner, D; Fahrleitner-Pammer, A The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review.
Wien Med Wochenschr. 2011; 161(23-24):565-570 Doi: 10.1007/s10354-011-0022-7
PubMed FullText FullText_MUG

 

2010

Reid, I; Miller, P; Brown, J; Kendler, D; Fahrleitner-Pammer, A; Valter, I; Maasalu, K; Bolognese, M; Woodson, G; Bone, H; Ding, B; Wagman, R; Martin, JS; Ominsky, M; Dempster, D; on behalf of the Denosumab Phase 3 Bone Histology Study Group Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies.
J Bone Miner Res. 2010; 25(10): 2256-2265. Doi: 10.1002/jbmr.149 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wagner, D; Fahrleitner-Pammer, A Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help?
Wien Med Wochenschr. 2010; 160(17-18): 452-457. Doi: 10.1007/s10354-010-0818-x
PubMed FullText FullText_MUG

 

2009

Brunasso, AM; Delfino, C; Ketabchi, S; Difonzo, EM; Massone, C Papules arising after radiotherapy for rhabdomyosarcoma.
Acta Dermatovenerol Alp Pannonica Adriat. 2009; 18(1):24-27 (- Case Report) [OPEN ACCESS]
PubMed FullText

 

Cummings, SR; San Martin, J; McClung, MR; Siris, ES; Eastell, R; Reid, IR; Delmas, P; Zoog, HB; Austin, M; Wang, A; Kutilek, S; Adami, S; Zanchetta, J; Libanati, C; Siddhanti, S; Christiansen, C; FREEDOM Trial Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
N Engl J Med. 2009; 361(8): 756-765. Doi: 10.1056/NEJMoa0809493 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fahrleitner-Pammer, A; Dobnig, H; Dimai, HP; Holzer, H; Benesch, T; Borchhardt, K; Cejka, D; Haas, M The effect of RANKL and OPG on bone mineral density in pre-dialysis chronic renal failure.
Clin Nephrol. 2009; Volume 71(June): 652-659. Doi: 10.5414/CNP71652
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Clar, H; Langsenlehner, U; Krippl, P; Renner, W; Leithner, A; Gruber, G; Hofmann, G; Yazdani-Biuki, B; Langsenlehner, T; Windhager, R A polymorphism in the G protein beta3-subunit gene is associated with bone metastasis risk in breast cancer patients.
Breast Cancer Res Treat. 2008; 111(3):449-452 Doi: 10.1007/s10549-007-9808-0
Web of Science PubMed FullText FullText_MUG

 

Fahrleitner-Pammer, A; Herberth, J; Browning, SR; Obermayer-Pietsch, B; Wirnsberger, G; Holzer, H; Dobnig, H; Malluche, HH Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease
J BONE MINER RES. 2008; 23(11): 1850-1858. Doi: 10.1359/jbmr.080610 [Poster] [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Dobnig, H; Hofbauer, LC; Viereck, V; Obermayer-Pietsch, B; Fahrleitner-Pammer, A Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients.
Osteoporos Int. 2006; 17(5):693-703 Doi: 10.1007/s00198-005-0035-4
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2005

Herrmann, M; Kraenzlin, M; Pape, G; Sand-Hill, M; Herrmann, W Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women.
Clin Chem Lab Med. 2005; 43(10):1118-1123 Doi: 10.1515/CCLM.2005.195
Web of Science PubMed FullText FullText_MUG

 

2004

Herrmann, M; Herrmann, W The assessment of bone metabolism in female elite endurance athletes by biochemical bone markers.
Clin Chem Lab Med. 2004; 42(12):1384-1389 Doi: 10.1515/CCLM.2004.258
Web of Science PubMed FullText FullText_MUG

 

2003

Fahrleitner-Pammer, A; Dobnig, H; Piswanger-Soelkner, C; Bonelli, C; Dimai, HP; Leb, G; Obermayer-Pietsch, B Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status.
Wien Klin Wochenschr. 2003; 115(9):291-297 Doi: 10.1007/BF03040334
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum